Active Wound Care Market Report 2025

The active wound care market size has grown strongly in recent years. It will grow from $1.51 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to increasing incidence of chronic wounds, rise in surgical procedures, prevalence of diabetes, patient preference for non-invasive treatments, government initiatives for wound care, awareness programs on wound management, growing focus on home healthcare.

The active wound care market size is expected to see strong growth in the next few years. It will grow to $2.25 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to global initiatives for wound healing, increasing geriatric population, personalized medicine approaches, demand for faster healing solutions, wound care in developing countries. Major trends in the forecast period include advanced wound dressings adoption, technological innovations in wound care products, bioactive and biodegradable materials, telemedicine and remote patient monitoring, economic considerations and cost-effective solutions.

The increasing number of diabetic patients globally is anticipated to drive the growth of the active wound care market in the coming years. Obesity, which results from excessively high blood glucose levels, can lead to sores and ulcers, thereby elevating the risk of infections and other severe complications. Active wound care treatment enables patients to engage in a structured healing process by applying various solutions and treatments to their wounds, which, in turn, boosts the demand for active wound care. For instance, a report published by the International Diabetes Federation (IDF) in December 2022 revealed that there are currently 537 million adults (ages 20-79) living with diabetes worldwide. This number is projected to rise to 643 million by 2030 and 783 million by 2045. Moreover, diabetes was responsible for 6.7 million deaths in 2021. Consequently, the growing prevalence of diabetes and related fatalities is expected to propel the growth of the active wound care market.

The growing aging population is expected to be a driving force behind the expansion of the active wound care market. This demographic shift towards an increased percentage of elderly individuals significantly influences healthcare needs, particularly regarding chronic wound management. Conditions like diabetic ulcers, pressure ulcers, and venous leg ulcers become more prevalent with age, emphasizing the importance of active wound care interventions. Technologies in active wound care, encompassing advanced dressings, regenerative therapies, and bioactive materials, cater to the specific needs of elderly patients, expediting wound healing and minimizing associated complications. With the World Health Organization projecting that by 2030, one in six people worldwide will be aged 60 or older, and by 2050, this age group's population will double to reach 2.1 billion, the rise in the aging populace is a key driver of the active wound care market.

Product innovation stands as a prominent trend gaining traction within the active wound care market. Leading companies within this sector are dedicated to developing novel solutions such as regenerative wound therapy and electrical stimulation technology to meet the evolving market demands. For instance, in January 2022, Accel-Heal Technologies Limited introduced Accel-Heal, a wearable electrical stimulation wound therapy device. This device, designed for easy home use, accelerates the healing process of chronic wounds, including challenging ones like diabetic foot ulcers. The innovation allows patients greater flexibility in receiving therapy, and healthcare professionals can integrate this therapy with existing dressing regimens, reducing the need for frequent nursing visits. The introduction of such advancements facilitates wider accessibility to electrical stimulation wound therapy, benefitting both patients and healthcare providers in managing chronic wounds effectively.

Prominent entities in the active wound care sector are actively introducing cutting-edge products leveraging silicone technology to maintain their competitive edge. Silicone technology involves the utilization of synthetic polymer materials known as silicones, comprised of silicon, oxygen, carbon, and hydrogen. Notably, in January 2023, Convatec, a UK-based medical products and technologies company, unveiled ConvaFoam, an advanced foam dressing engineered to meet healthcare providers' and patients' specific needs. ConvaFoam integrates enhanced silicone technology to offer superior adhesion, improved fluid absorption, a prolonged wear duration of seven days, and incorporates a patterned film design aiding in exudate monitoring. Going beyond standard bandages, ConvaFoam simplifies wound care complexities, providing valuable assistance to both patients and healthcare practitioners in addressing prevailing healthcare challenges.

In October 2024, Mölnlycke Health Care, a Sweden-based medical device company, acquired P.G.F. Industry Solutions GmbH for an undisclosed amount. This acquisition is aimed at strengthening Mölnlycke Health Care's market position, expanding its product offerings, and enhancing innovation in wound care and surgical solutions. P.G.F. Industry Solutions GmbH is an Austria-based pharmaceutical company that specializes in manufacturing Granudacyn wound cleansing and moistening solutions.

Major companies operating in the active wound care market are Smith & Nephew PLC, MiMedx Group Inc., Tissue Regenix Group, Organogenesis Inc., Acell Inc., Integra Life Sciences Holdings Corporation, Solsys Medical LLC, Osiris Therapeutics Inc., Cytori Therapeutics Inc., Human BioSciences Inc., Wright Medical Group NV, Mölnlycke Health Care AB, Medline Industries Inc., AVITA Medical Inc., ConvaTec Inc., Stryker Corporation, 3M Company, Acelity L.P. Inc., B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health Inc., Celularity Inc., Coloplast A/S, Generex Biotechnology Corp., Hollister Incorporated, Johnson & Johnson Inc., Lohmann & Rauscher GmbH & Co. Kg, Medtronic PLC, PAUL HARTMANN AG, Adynxx Inc., Derma sciences Inc., Baxter International Inc., Axio Biosolutions.

North America was the largest region in the active wound care market in 2024. The regions covered in the active wound care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the active wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Active wound care involves the process of removing devitalized and necrotic tissue to facilitate healing. Products used in active wound care include specialized dressings like films, foams, and hydrogels, which serve as physical barriers against infection. The primary objectives of active wound care are to debride damaged skin tissues, control infection and pain, and stimulate the growth of new tissue.

The main types of active wound care biomaterials include skin substitutes, synthetic skin substitutes, and growth factors. These biomaterials function as barriers against infections, supporting the body's natural healing response for effective wound healing. Active wound care is applied to address various indications such as burns, diabetic foot ulcers, pressure ulcers, and lower limb ulcers, catering to both chronic and acute wounds. End-users of active wound care products span across hospitals, clinics, home care settings, and other healthcare facilities.

The active wound care market research report is one of a series of new reports that provides active wound care market statistics, including active wound care industry global market size, regional shares, competitors with an active wound care market share, detailed active wound care market segments, market trends and opportunities, and any further data you may need to thrive in the active wound care industry. This active wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The active wound care market consists of sales of allografts, synthetic skin grafts, xenografts, collagen dressings, and amniotic tissue grafts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.